Form 4: Cardlytics CFO Alexis DeSieno Reports Stock Transactions
SEC Form 4 Filing
Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.
Summary
- Alexis DeSieno, CFO of Cardlytics, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On May 14, 2025, DeSieno acquired 43,750 shares of common stock through the vesting of restricted stock units (RSUs).
- On May 15, 2025, DeSieno sold 26,217 shares of common stock at an average price of $1.938 to cover tax withholding obligations related to the RSU vesting.
- Following these transactions, DeSieno directly owns 164,833 shares of Cardlytics common stock.
- DeSieno also directly owns 43,750 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider trading. It doesn't convey strong positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect the company's overall performance or future prospects but offers insight into management's individual financial decisions.
Stakeholder Impact
- The sale of shares by the CFO could have a minor impact on shareholders, but it is primarily related to tax obligations and not necessarily indicative of the CFO's view on the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Anniversary Date: 50% of the RSUs vested. |
| 05/14/2025 | Date of RSU vesting and acquisition of 43,750 shares. |
| 05/15/2025 | Date of sale of 26,217 shares to cover tax obligations. |
| 05/16/2025 | Date of signature on the Form 4 filing. |
Keywords
Cardlytics, CDLX, Form 4, Beneficial Ownership, Alexis DeSieno, CFO, Stock Transactions, Restricted Stock Units, RSU, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.